The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells

BACKGROUND: The inhibition of Breast Cancer 1 (BRCA1) expression sensitizes breast and ovarian cancer cells to platinum chemotherapy. However, therapeutically relevant agents that target BRCA1 expression have not been identified. Our recent report suggested the potential of the histone deacetylase (...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Weberpals, Johanne I, O'Brien, Anna M, Niknejad, Nima, Garbuio, Kyla D, Clark-Knowles, Katherine V, Dimitroulakos, Jim
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Primary Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3175148/
https://ncbi.nlm.nih.gov/pubmed/21854619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-11-29
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы